Urologicheskie i andrologicheskie zabolevaniya pri sakharnom diabete


如何引用文章

全文:

详细

参考

  1. Ayta I. A., McKinlay J. B., Krane R. J. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. Br. J. Urol. Int. 1999; 84: 50-56.
  2. Craig A. One in ten. London: Impotence Association; 1998.
  3. Vinik A., Richardson D. Erectile dysfunction in diabetes. Diabet. Rev. 1998; 6 (1): 16-33.
  4. Brunner G. A., Pieber T. R., Schattenberg S. et al. Erectile dysfunction in patients with type I diabetes mellitus. Wien. Med. Wschr. 1995; 145 (21): 584-586.
  5. El-Rufaie O. E., Bener A., Abuzeid M. S., Ali T. A. Sexual dysfunction among type II diabetic men: a controlled study. J. Psychosom. Res. 1997; 43 (6): 605-612.
  6. Eardley I., Gale E. Diabetic impotence. In: Kirby R. S., Carson C. C., Webster G. D., eds. Impotence diagnosis and management of erectile dysfunction. Butterworth-Heinemann; 2001.
  7. Bancroft J., Gutierrez P. Erectile dysfunction in men wit and without diabetes mellitus: a comparative study. Diabet. Med. 1996; 13 (1): 84-89.
  8. Роживанов Р. В. Эректильная дисфункция у больных сахарным диабетом: скрининг, структура, прогностическое значение: Дис. ... канд. мед. наук. М.; 2005.
  9. Bacon C. G., Hu F. B., Giovanucci E. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabet. Care 2002; 25 (8): 1417.
  10. Коган М. И. (ред.). Нарушения половой функции у мужчин при сахарном диабете. М.; 2005.
  11. Fedele D., Bortolotti A., Coscelli C. et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy. Int. J. Epidemiol. 2000; 29: 524-531.
  12. Jonler M., Moon T., Brannan W. et al. The effect of age, ethnicity and geographical location on impotence and quality of life. Br. J. Urol. 1995; 75: 651-655.
  13. De la Vega J. S., Amaya Gutierrez J., Alonso Flores J. J. et al. Erectile dysfunction in those under 40. Etiological and contributing factors. Arch. Esp. Urol. 2003; 56 (2): 161-164.
  14. Whitehead E. D., Klyde B. J. Diabetes-related impotence in the elderly. Clin. Geriatr. Med. 1990; 6: 771-795.
  15. Sullivan M. E., Thompson C. S., Dashwood M. R. et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc. Res. 1999; 43 (3): 58-65.
  16. Siu S. C., Lo S. K., Wong K. W. et al. Prevalence of and risk factors for erectile dysfunction in Hong Kong diabetic patients. Diabet. Med. 2001; 18 (9): 732-738.
  17. Romeo J. H., Seftel A. D., Madhun Z. T., Aron D. C. Sexual function in men with diabetes type 2: association with glycemic control. J. Urol. (Baltimore) 2000; 163 (3): 788-791.
  18. Naya Y., Mizutani Y., Ochiai A. et al. Preliminary report of association of chronic diseases and erectile dysfunction in middle-aged men in Japan. Urology 2003; 62 (3): 532-536.
  19. Shiri R., Koskimaki J., Hakama M. et al. Effect of chronic diseases on incidence of erectile dysfunction. Urology 2003; 62 (6): 1097-1102.
  20. Klein R., Klein B. E., Lee K. E. et al. Prevalence of selfreported erectile dysfunction in people with long-term IDDM. Diabet. Care 1996; 19 (2): 135-141.
  21. Tesfaye S., Stevens L. K., Stephenson J. M. et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384.
  22. Фомкин Р. Г. Патогенез, диагностика и лечение эректильной дисфункции при сахарном диабете: Дис. ? канд. мед. наук. Ростов-н/Д.; 2001.
  23. Hakim L. S., Goldstein I. Diabetic sexual dysfunction. Endocrinol. Metab. Clin. N. Am. 1996; 25: 379-400.
  24. Harati Y. Diabetes and the nervous system. Endocrinol. Metab. Clin. Chron. Complicat. Diabet. 1996; 25 (2): 552-607.
  25. O'Hare J. A., Abuaisha F., Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir. J. Med. Sci. 1994; 163: 132-135.
  26. Vardi Y., Sprecher E., Kanter Y. et al. Polyneuropathy in impotence. Int. J. Impot. Res. 1996; 8 (2): 65-68.
  27. Vinik A. I., Maser R. E., Mitchell B. D., Freeman R. Diabetic autonomic neuropathy. Diabet. Care 2003; 26 (5): 1553-1579.
  28. Ziegler D. Clinical aspects, diagnosis and therapy of diabetic neuropathy. Ther. Umsch. 1996; 53 (12): 948-957.
  29. Rozhivanov R. V., Kalinchenko S. Yu. Neurological criteria of neurogenic erictile dysfunction diagnostics in patients with diabetes. In: Abstracts of 3-rd European congress of andrology, Munster, Germany, 11-14 Sept. 2004. Munster; 2004. 193.
  30. Benvenuti F., Boncinelli L., Vignoli G. C. Male sexual impotence in diabetes mellitus: vasculogenic versus neurogenic factors. Neurourol. and Urodyn. 1993; 12: 145-151.
  31. Kloner R. A., Speakman M. Erectile dysfunction and atherosclerosis. Curr. Atheroscler. Rep. 2002; 4 (5): 397-401.
  32. Nisen I. O., Alfthan O. S., Lindstrom B. L. et al. Cardiovascular reflexes in the neurological evaluation of impotence. Br. J. Urol. 1993; 71 (2): 199-203.
  33. Kayigil O., Atahan O., Metin A. Multifactorial evaluation of diabetic erectile dysfunction. Int. Urol. Nephrol. 1996; 28 (5): 717-721.
  34. Walczak M. K., Lokhandwala N., Hodge M. B., Guay A. T. Prevalence of cardiovascular risk factors in erectile dysfunction. J. Gend. Specif. Med. 2002; 5 (6): 19-24.
  35. Metro M. J., Broderick G. A. Diabetes and vascular impotence: does insulin dependence increase the relative severity? Int. J. Impot. Res. 1999; 11 (2): 87-89.
  36. Зубарев А. Р., Митькова М. Д., Корякин М. В., Митьков В. В. Ультразвуковая диагностика заболеваний наружных половых органов у мужчин. М.; 1999.
  37. Кротовский Г. С., Зудин А. М. Виагра - пять лет успеха. М.; 2003.
  38. Jevtich M. J., Kass M., Khawand N. Changes in the corpora cavernosa of impotent diabetics: comparing histological with clinical findings. J. Urol. (Paris) 1985; 91: 281-285.
  39. Seftel A. D., Vaziri N. D., Ni Z. et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 1997; 50 (6): 1016-1026.
  40. Hayashi K., Takamizawa K., Nakamura T. et al. Effects of elastase on the stiffness and elastic properties of arterial walls in cholesterol-fed rabbits. Atherosclerosis 1987; 66: 259-267.
  41. Bar-Moshe O., Vandendris M. Treatment of impotence due to perineal venous leakage by ligation of crura penis. J. Urol. (Baltimore) 1988; 139: 1217-1219.
  42. El-Sakka A. I. Penile axial rigidity and Doppler ultrasonography parameters in patients with erectile dysfunction: association with type 2 diabetes. Urology 2003; 62 (3): 525-531.
  43. Dhindsa S., Prabhakar S., Sethi M. et al. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J. Clin. Endocrinol. 2004; 89 (11): 5462-5468.
  44. Rossi P., Menchini Fabris F., Fiorini I. et al. Comparison between plasma concentrations of testosterone, nitric oxide an endothelin 1-2 in penile an brachial venous blood: preliminary results in men with psychogenic impotence. Biomed. and Pharmacother. 1998; 52 (7-8): 308-310.
  45. Schirar A., Chang C., Rousseau J. P. Localization of androgen receptor in nitric oxide synthase- an vasoactive intestinal peptide-containing neurons of the major pelvic ganglion innervating the rat penis. J. Neuroendocrinol. 1997; 9 (2): 141-150.
  46. Schiavi R. C., White D., Mandeli J., Schreiner-Engel P. Hormones nd nocturnal penile tumescence in healthy aging men. Arch. Sex. Behav. 1993; 22 (3): 207-215.
  47. Alexopoulou O., Jamart J., Maiter D. et al. Erectile dysfunction and lower androgenicity in type 1 diabetic patients. Diabet. Metab. 2001; 27 (3): 329-336.
  48. Baskin H. J. Endocrinologic evaluation of impotence. South. Med. J. 1989; 82 (40): 446-449.
  49. Cunningham M. J., Clifton D. K., Steiner R. A. Leptin's actions on the reproductive axis: perspectives an mechanisms. Biol. Reprod. 1999; 60: 216-222.
  50. Дедов И. И., Калинченко С. Ю. Возрастной андрогенный дефицит у мужчин. М.; 2006.
  51. Ермачек Е. А. Влияние пероральной сахароснижающей терапии на андрогенный статус и состояние половой функции у мужчин с сахарным диабетом типа 2: Дис. ? канд. мед. наук. М.; 2007.
  52. Veves A., Webster L., Chen T. F. et al. Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. Diabet. Med. 1995; 12 (1): 77-82.
  53. De Berardis G., Franciosi M., Belfiglio M. et al. The Quality of Care and Outcomes in Type 2 Diabetes (QuED) Study Group: Erectile dysfunction and quality of life in type 2 diabetic patients. Diabet. Care 2002; 25: 284-291.
  54. Rubin R. R., Peyrot M. Persistence of depressive symptoms in diabetic adults. Diabet. Care 1999; 22 (3): 448-452.
  55. Carton J. A., Maradona J. A., Nuno F. J. et al. Diabetes mellitus and bacteraemia: a comparative study between diabetic and nondiabetic patients. Eur. J. Med. 1992; 1: 281-287.
  56. Rendell M. S., Rajfer J., Wicker P. A., Smith M. D. For the Sildenafil Diabetes Study Group: Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. J. A. M. A. 1999; 281: 421-426.
  57. Willke R. J., Yen W., Parkerson G. R. et al. Quality of life effects of alprostadil therapy for erectile dysfunction: results of a trial in Europe and South Africa. Int. J. Impot. Res. 1998; 10: 239- 246.
  58. Enzlin P., Chantal M., Van Den Bruel A. et al. Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabet. Care 2003; 26: 409-414.
  59. Кратохвил С. Психотерапия семейно-сексуальных дисгармоний. М.; 1991.
  60. Richardson D., Nalabanda A., Goldmeier D. Retarded ejaculation ? a review. Int. J. STD AIDS 2006; 17: 143-150.
  61. Nicolosi A., Glasser D. B., Brock G. et al. Diabetes and sexual function in older adults: results of an inernational survey. Br. J. Diabet. Vasc. Dis. 2002; 2: 336-339.
  62. Takahashi Y., Iwamoto Y. Sexual dysfunction in diabetes mellitus. Nippon Rinsho 1997; 55 (11): 2991-2995.
  63. Chartier-Kastler E., Averous M., Barrou B. et al. Diabetes and urination disorders. Progr. Urol. 2000; 10 (1): 14-23.
  64. Hill S. R., Fayyad A. M., Jones G. R. Diabetes mellitus and female lower urinary tract symptoms. Neurourol. and Urodyn. 2007.
  65. Hunter K. F., Moore K. N. Diabetes-associated bladder dysfunction in the older adult (CE). Geriatr. Nurs. 2003; 24 (3): 138- 145.
  66. Hampel C., Gillitzer R., Pahernik S. et al. Diabetes mellitus an bladder function. What should be considered? Urologe A 2003; 42 (12): 1556-1563.
  67. Yang Z., Dolber P. C., Fraser M. O. Diabetic urethropathy compounds the effects of diabetic cystopathy. J. Urol. (Baltimore) 2007; 178 (5): 2213-2219.
  68. Kebapc N., Yenilmez A., Efe B. et al. Bladder dysfunction in type 2 diabetic patients. Neurourol. and Urodyn. 2007; 26: 814-819.
  69. Esteghamati A., Rashidi A., Nikfallah A., Yousefizadeh A. The association between urodynamic findings and microvascular complications in patients with long-term type 2 diabetes but without voiding symptoms. Diabetes Res. Clin. Pract. 2007; 78 (1): 42- 50.
  70. Michel M. C., Mehlburger L., Schumacher H. et al. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J. Urol. (Baltimore) 2000; 163: 1725- 1729.
  71. Sarma A. V. Association between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling black and white men. Diabet. Care 2008; 31: 476-482.
  72. Dib P. T., Trigo-Rocha F., Gomes C. M., Srougi M. Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms. Urol. Int. 2008; 80 (4): 378-382.
  73. Parsons J. K., Carter H. B., Partin A. W. et al. Metabolic factors associated with benign prostatic hyperplasia. J. Clin. Endocrinol. 2006; 91 (7): 2562-2568.
  74. Hammarsten J., Högstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press. 1999; 8 (1): 29-36.
  75. Дедов И. И., Шестакова М. В. Диабетическая нефропатия. М.; 2000.
  76. Geerlings S. E., Stolk R. P., Camps M. J. et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Mellitus Women Asymptomatic Bacteriuria Utrecht Study Group. Diabet. Care 2000; 23: 744-749.
  77. Joshi N., Caputo G. M., Weitekamp M. R., Karchmer A. W. Infections in patients with diabetes mellitus. N. Engl. J. Med. 1999; 341: 1906-1912.
  78. Ludwig E. Urinary tract infections in diabetes mellitus. Orv. Hetil. 2008; 149 (13): 597-600.
  79. Geerlings S. E., Brouwer E. C., Van Kessel K. C. et al. Cytokine secretion is impaired in women with diabetes mellitus. Eur. J. Clin. Invest. 2000; 30: 995-1001.
  80. Geerlings S. E., Meiland R., van Lith E. C. et al. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabet. Care 2002; 25: 1405-1409.
  81. Geerlings S. E. Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment. Int. J. Antimicrob. Agents 2008; 31 (suppl. 1): 54-57.
  82. Mulvey M. A., Schilling J. D., Martinez J. J. et al. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc. Natl. Acad. Sci. USA 2000; 97 (16): 8829-8835.
  83. Geerlings S. E., Stolk R. P., Camps M. J. L. et al. Risk factors for symptomatic urinary tract infection in women with diabetes mellitus. Diabet. Care 2000; 23 (12): 1737-1741.
  84. Hooton T. M., Scholes D., Stapleton A. E. et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N. Engl. J. Med. 2000; 343 (14): 992-997.
  85. Забиров К. И., Деревянко И. И., Марчук Н. В. Современные аспекты проблемы баланопостита. Consilium Medicum 2004; 6 (3).
  86. Hoepelman A. I., Meiland R., Geerlings S. E. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int. J. Antimicrob. Agents 2003; 22 (suppl. 2): 35-43.
  87. Dutta P., Bhansali A., Singh S. K. et al. Presentation and outcome of emphysematous renal tract disease in patients with diabetes mellitus. Urol. Int. 2007; 78 (1): 13-22.
  88. Guillausseau P. J., Farah R., Laloi-Michelin M. et al. Urinary tract infections and diabetes mellitus. Rev. Prat. 2003; 53 (16): 1790-1796.

补充文件

附件文件
动作
1. JATS XML
##common.cookie##